| 8.01 Data as of Jun 18 |  +0.08 / +1.01%Today’s Change | 5.42 Today|||52-Week Range 11.36 | 0.00% Year-to-Date |
| 5 Stocks Seeing Bullish Options Activity Jun 13 / TheStreet.com |
| Previous close | 7.93 |
| Today’s open | 7.96 |
| Day’s range | -- - -- |
| Volume | 952,773 |
| Average volume (3 months) | 1,021,463 |
| Market cap | $765.7M |
| Dividend yield | -- |
| Earnings growth (last year) | +7.25% |
| Earnings growth (this year) | -0.79% |
| Earnings growth (next 5 years) | +4.57% |
| Revenue growth (last year) | +955.47% |
| P/E ratio | NM |
| Price/Sales | 227.26 |
| Price/Book | 8.76 |
| Today’s change | Today’s % change | |
|---|---|---|
| OPTROptimer Pharmaceutic... | +0.01 | +0.07% |
| INFIInfinity Pharmaceuti... | +2.29 | +13.34% |
| NBIXNeurocrine Bioscienc... | -0.02 | -0.16% |
| AUXLAuxilium Pharmaceuti... | +0.10 | +0.58% |
| Next reporting date | August 7, 2013 |
| EPS forecast (this quarter) | -$0.15 |
| Annual revenue (last year) | $2.6M |
| Annual profit (last year) | -$47.1M |
| Net profit margin | -1,807.71% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Milind S. Deshpande, PhD |
CFO, Secretary, SVP & Head-Investor Relations Mary Kay Fenton, MBA, CPA |
Corporate headquarters New Haven, Connecticut |
.
